SCHEMBL5135905

SCHEMBL5135905

CCCCn1c(-c2ccccc2)nc(-c2ccccc2)c1CN(Cc1ccc(OC)cc1)Cc1ccc(Cl)c(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 1/20 0.45
NR1I3 Q14994 1/20 0.40
SMN1; SMN2 Q16637 5/20 0.37
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 4/20 0.37
LMNA P02545 3/20 0.37
HTT P42858 3/20 0.37
TSHR P16473 3/20 0.37
GAA P10253 3/20 0.37
NPSR1 Q6W5P4 2/20 0.37
CNR2 P34972 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TP53 P04637 4/20 0.37
MAPT P10636 3/20 0.37
HPGD P15428 1/20 0.37
BCHE P06276 3/20 0.36
BLM P54132 1/20 0.36
TLR7 Q9NYK1 1/20 0.36
TSPO P30536 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5136898 0.92 C5AR1 (0.43) C5AR1SMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL651365 0.92 C5AR1 (0.46) C5AR1SMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL5137368 0.91 TP53 (0.46) C5AR1SMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL5072205 0.91 C5AR1 (0.46) C5AR1SMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL5136291 0.90 C5AR1 (0.45) C5AR1SMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL4766354 0.89 C5AR1 (0.41) C5AR1SMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL5136545 0.89 C5AR1 (0.43) C5AR1SMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL648419 0.89 C5AR1 (0.46) C5AR1SMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL5134952 0.89 C5AR1 (0.44) C5AR1SMN1; SMN2ALDH1A1KDM4ELMNA
SCHEMBL5136185 0.89 C5AR1 (0.44) C5AR1SMN1; SMN2ALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490044-A4 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORP (US) 2008-04-16 EP disclosed
EP-1490044-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2004-12-29 EP disclosed
WO-2003084524-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2003-10-16 WO disclosed